Fairfield Financial Advisors’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-100	Closed	-$13.7K	–	149
2024 Q4	$13.7K	Hold	100	–	–	﹤0.01%	189
2024 Q3	$11.5K	Hold	100	–	–	﹤0.01%	218
2024 Q2	$13.8K	Buy	+100	New	+$13.8K	﹤0.01%	193
2023 Q4	$13.2K	Buy	+100	New	+$13.2K	0.01%	222